# Amwill Health (NSE: AMWILL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/AMWILL · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹89 Cr, it ranks 2733rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Distribution.

Its return on equity was 15.5% in FY25. Promoters held 70.65% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹89 Cr |
| ROE | 15.5% (FY25) |
| ROCE | 17.1% (FY25) |
| Debt to equity | 0 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹41 Cr | ₹11 Cr |
| FY24 | ₹44 Cr | ₹13 Cr |
| FY23 | ₹30 Cr | ₹3 Cr |
| FY22 | ₹28 Cr | ₹3 Cr |
| FY21 | ₹18 Cr | −₹1 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 70.65%
- Non-institutions: 29.35%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Concord Drugs](https://app.pivotnow.in/stock/CONCORD) | — | ₹101 Cr | — | — |
| [Denis Chem Lab](https://app.pivotnow.in/stock/DENISCHEM) | — | ₹101 Cr | — | — |
| [Fortis Malar](https://app.pivotnow.in/stock/FORTISMLR) | — | ₹97 Cr | — | — |
| [Raaj Medisafe](https://app.pivotnow.in/stock/RAAJMEDI) | — | ₹97 Cr | — | — |
| [KHFM HOSPITALIT](https://app.pivotnow.in/stock/KHFM) | ₹40.90 | ₹95 Cr | — | — |
| [Modern Diagnost](https://app.pivotnow.in/stock/MDRC) | — | ₹81 Cr | — | — |

## Questions and answers

### What is the market cap of Amwill Health?

Amwill Health's market capitalisation is ₹89 Cr (₹89 Cr) at the 22 Oct 2026 close, ranking 2733rd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Amwill Health?

Return on equity was 15.5% in FY25 and return on capital employed was 17.1% in FY25 (standalone figures).

### Is Amwill Health a debt-free company?

Amwill Health is close to debt-free: its debt-to-equity ratio was 0 in FY25.

### What is the shareholding pattern of Amwill Health?

As of 31 Mar 2026: promoters 70.65%, non-institutions 29.35%.

### Who are Amwill Health's competitors?

The listed Pharma & Healthcare companies closest to Amwill Health by market cap are Concord Drugs, Denis Chem Lab, Fortis Malar, Raaj Medisafe, KHFM HOSPITALIT and Modern Diagnost.

### Is Amwill Health a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Amwill Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AMWILL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.